Skip to content

Evaluation of the i-gel supraglottic airway.

Evaluation of the i-gel supraglottic airway compared to a standard disposable laryngeal mask airway during Spontaneous and Continuous Positive Pressure Ventilation (CPPV) in patients receiving anesthesia for (non-thoracic, non-abdominal) elective surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25310
Enrollment
240
Registered
2007-10-28
Start date
2007-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. i-gel

Interventions

Randomisation to i-gel or disposable laryngeal mask.

Sponsors

The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Plesmanlaan 121 1066 CX Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA 1-2; 2. Adults (age 18 to 80 years); 3. Weight 40 – 100 kg; 4. Elective procedures; 5. Non-thoracic, non-abdominal surgery; 6. Non-pregnant; 7. Non-symptomatic of regurgitation.

Exclusion criteria

Exclusion criteria: 1. ASA 3 and above; 2. Below the age of 18 or above the age of 80; 3. Weight than 100kg; 4. Full stomach or symptomatic with regurgitation or retained gastric contents; 5. Thoracic or abdominal surgery; 6. Emergency surgery/anaesthetics; 7. Pregnancy; 8. Known difficult airway; 9. Expected difficult airway: Mallampati grade IV or mouth opening less than 2.5 cm; 10. Patients with head and neck cancer.

Design outcomes

Primary

MeasureTime frame
Comparing the incidence of postoperative sore throat after 1, 24 and 48 hours.

Secondary

MeasureTime frame
Comparing insertion and ventilation parameters, maximum seal power and fibre-optic evaluation of device position of the two supraglottic airway devices.

Contacts

Public ContactC. Keijzer

NKI, Plesmanlaan 121

c.keijzer@nki.nl+31 20-5129111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)